It has been over a year since the world saw the first confirmed case of COVID-19, yet the science behind the virus’ physical impact on children remains relatively unclear. Kathryn Cleary spoke to two experts in paediatrics and immunology to get an update on what we have learnt so far.
South Africa is set to produce its first vaccine in 25 years, but it won’t be a COVID-19 jab. Plans are however in place to “fill and finish” COVID-19 vaccines in South Africa. Laura Lopez Gonzalez has the details.
There is much talk in South Africa about a ‘second wave’ of COVID-19. In Europe, it is much more than talk, with COVID-19 diagnoses, hospital admissions, and deaths, not to mention ‘restrictions’, all on the rise. Alex Welte places in perspective what we do and do not know about herd immunity and potential second waves.
How many people have actually died of COVID-19 in South Africa and what do we know about the possibility of a second wave? As the first, and hopefully the only, substantial wave of infections and death recedes, Spotlight Editor Marcus Low assesses the many remaining uncertainties.
The South African National Institute for Communicable Diseases on Tuesday declared multi-system inflammatory syndrome in children (MIS-C) a Notifiable Medical Condition. Elna Schütz spoke with doctors who have been treating this rare and dangerous condition.
Initial results from an antibody survey conducted in the Cape Town Metro indicate that of 2 700 pregnant women and people living with HIV making use of the public healthcare system, 40% have previously been infected with SARS-CoV-2. Adele Baleta has the details.
Immunity to COVID-19 is much more interesting and much more complicated than simply something you do or do not have. Kathryn Cleary spoke to two experts about what we know about COVID-19 immunity and the implications of that for antibody testing and the development of vaccines.